US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Zenas BioPharma Inc.

31.29

-1.0050-3.11%

Volume:16.07K

Turnover:508.23K

Market Cap:2.04B

PE:-3.46

High:32.48

Open:32.40

Low:31.12

Close:32.29

52wk High:44.60

52wk Low:13.50

Shares:65.18M

Float Shares:39.84M

Volume Ratio:0.27

T/O Rate:0.04%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-9.0522

EPS(LYR):-8.4448

ROE:-199.04%

ROA:-34.42%

PB:8.25

PE(LYR):-3.70

Loading ...

Overview Company News Filings

China's InnoCare Pharma H1 Revenue Surges, Partly on Orelabrutinib Growth

Zenas BioPharma Grants 11,000 RSUs to Newly Hired Employees Under 2026 Inducement Plan

Zenas Biopharma Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

THOMSON REUTERS

Zenas BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Zenas BioPharma reports Q2 EPS ($1.77), consensus (75c)

Zenas BioPharma CFO Jennifer Fox to transition out of role

Zenas BioPharma Price Target Maintained with a $45.00/Share by Wedbush

Morgan Stanley Reaffirms Their Hold Rating on Zenas BioPharma, Inc. (ZBIO)

Zenas BioPharma, Inc. (ZBIO) Receives a Buy from Guggenheim

Analysts Offer Insights on Healthcare Companies: MDxHealth (MDXH), Opko Health (OPK) and Zenas BioPharma, Inc. (ZBIO)

Zenas BioPharma Searches for CFO as Fox Transitions to Advisory Role

Zenas BioPharma, Inc. Reports Results for the Quarter Ended June 30 - Earnings Summary

Zenas BioPharma Q2 EPS $(1.77) Misses $(1.08) Estimate, Sales $1.000M Miss $18.750M Estimate

Benzinga Earnings

Zenas Biopharma Posts Corporate Presentation on Autoimmune Disease Pipeline, Led by Obexelimab Program

Earnings Flash (ZBIO) Zenas BioPharma Posts Q2 Loss $1.77 a Share, vs. FactSet Est of $1.12 Loss

MT Newswires Live

Zenas BioPharma Q2 FY26 Net Loss Widens to $111.5 Million; Revenue Rises to $1 Million

Zenas Biopharma, Inc.: Qtrly EPS $-1.77

THOMSON REUTERS

Press Release: Zenas BioPharma Reports Second Quarter 2026 Financial Results and Provides Corporate Update

Biopharma Firm Xencor's Q2 Revenue Beats on Royalty Revenue, Milestone Payments

Zenas BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.gotigerhk.com/stock/ZBIO/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"ZBIO","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ZBIO\",,,,,undefined,":{"symbol":"ZBIO","market":"US","secType":"STK","nameCN":"Zenas BioPharma Inc.","latestPrice":31.285,"timestamp":1787579392618,"preClose":32.29,"halted":0,"volume":16072,"delay":0,"changeRate":-0.0311241870548157,"floatShares":39841600,"shares":65176700,"eps":-9.052203,"marketStatus":"Trading","change":-1.005,"latestTime":"08-24 09:49:54 EDT","open":32.4,"high":32.48,"low":31.12,"amount":508234.81100000005,"amplitude":0.042118,"askPrice":31.41,"askSize":84,"bidPrice":31.2,"bidSize":156,"shortable":3,"etf":0,"ttmEps":-9.052203,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1787601600000},"marketStatusCode":2,"adr":0,"adrRate":0,"listingDate":1726200000000,"exchange":"NASDAQ","adjPreClose":32.29,"sharesOutstanding":249967,"nav":10.0592,"aum":2514468.0464,"bidAskSpread":0,"preHourTrading":{"tag":"盘前","latestPrice":32.29,"preClose":32.29,"latestTime":"08:19 EDT","volume":2,"amount":64.57,"timestamp":1787573977491,"change":0,"changeRate":0,"amplitude":0.00031},"postHourTrading":{"tag":"盘后","latestPrice":33,"preClose":32.29,"latestTime":"19:42 EDT","volume":61660,"amount":1992337.9695,"timestamp":1787355753598,"change":0.71,"changeRate":0.021988,"amplitude":0.021988},"volumeRatio":0.268604,"impliedVol":0.8445,"impliedVolPercentile":0.4143},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ZBIO\",,,,,undefined,":{"symbol":"ZBIO","floatShares":39841600,"roa":"-34.42%","roe":"-199.04%","lyrEps":-8.444814,"volumeRatio":0.268604,"shares":65176700,"dividePrice":0,"high":32.48,"amplitude":0.042118,"preClose":32.29,"low":31.12,"week52Low":13.5,"pbRate":"8.25","psRate":"2039.05","week52High":44.6,"institutionHeld":0,"latestPrice":31.285,"committee":0.3,"eps":-9.052203,"divideRate":0,"volume":16072,"delay":0,"ttmEps":-9.052203,"open":32.4,"prevYearClose":36.31,"prevWeekClose":32.29,"prevMonthClose":31.44,"prevQuarterClose":25.38,"fiveDayClose":30.5,"twentyDayClose":32.82,"sixtyDayClose":18.56},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ZBIO\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-13","symbol":"ZBIO","fiscalQuarterEnding":"2026/06","expectedEps":-0.89,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1786593600000,"reportTimeType":"pre","actualEps":-1.77},{"market":"US","date":"2026-05-13","symbol":"ZBIO","fiscalQuarterEnding":"2026/03","expectedEps":-1.37,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1778644800000,"reportTimeType":"pre","actualEps":-1.46},{"market":"US","date":"2026-03-16","symbol":"ZBIO","fiscalQuarterEnding":"2025/12","expectedEps":-1.22,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1773633600000,"reportTimeType":"pre","actualEps":-4.54},{"market":"US","date":"2025-11-12","symbol":"ZBIO","fiscalQuarterEnding":"2025/09","expectedEps":-0.87,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1762923600000,"reportTimeType":"pre","actualEps":-1.22},{"market":"US","date":"2025-08-12","symbol":"ZBIO","fiscalQuarterEnding":"2025/06","expectedEps":-1.02,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1754971200000,"reportTimeType":"pre","actualEps":-1.25}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ZBIO\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ZBIO\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.625,"buy":0.25,"hold":0.125,"sell":0,"strongSell":0,"meanLabel":"STRONG BUY","meanPercent":0.625,"analysts":8,"updateTime":1767758400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/ZBIO\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"ZBIO","date":"2026-08-21","current":-3.567087,"percent":0.421488,"low":-19.592941,"twenty":-7.371525,"median":-3.831007,"eighty":-2.614149,"high":-1.802568,"avg":-5.311132,"sd":3.731751,"marketCap":2060887981},"quantilePoints":[{"date":"2024-09-13","current":-8.364044,"twenty":-11.189626,"median":-10.130033,"eighty":-9.07044,"marketCap":457989962},{"date":"2024-09-20","current":-12.731934,"twenty":-12.968841,"median":-12.731934,"eighty":-9.523082,"marketCap":697162515},{"date":"2024-09-27","current":-12.564791,"twenty":-13.484804,"median":-12.909978,"eighty":-12.029776,"marketCap":688010267},{"date":"2024-10-04","current":-14.275075,"twenty":-13.747873,"median":-12.811872,"eighty":-12.31335,"marketCap":781660299},{"date":"2024-10-11","current":-13.008553,"twenty":-13.941177,"median":-13.027627,"eighty":-12.397648,"marketCap":712309358},{"date":"2024-10-18","current":-16.373229,"twenty":-14.273549,"median":-13.29848,"eighty":-12.477586,"marketCap":896548905},{"date":"2024-10-25","current":-17.845752,"twenty":-15.022781,"median":-13.503182,"eighty":-12.59822,"marketCap":977179818},{"date":"2024-10-31","current":-16.022265,"twenty":-16.022265,"median":-13.891034,"eighty":-12.731934,"marketCap":877331175},{"date":"2024-11-08","current":-15.961228,"twenty":-15.961228,"median":-14.267446,"eighty":-12.811872,"marketCap":873988961},{"date":"2024-11-15","current":-6.06727,"twenty":-16.022265,"median":-14.202594,"eighty":-12.564791,"marketCap":782495852},{"date":"2024-11-22","current":-3.382919,"twenty":-15.961228,"median":-13.807463,"eighty":-11.896022,"marketCap":436298426},{"date":"2024-11-29","current":-3.729636,"twenty":-15.955124,"median":-13.496851,"eighty":-6.578437,"marketCap":481014835},{"date":"2024-12-06","current":-3.402361,"twenty":-15.898664,"median":-13.178717,"eighty":-4.851473,"marketCap":438805888},{"date":"2024-12-13","current":-2.997318,"twenty":-15.744546,"median":-13.008553,"eighty":-3.729636,"marketCap":386567092},{"date":"2024-12-20","current":-3.162575,"twenty":-15.636205,"median":-12.771903,"eighty":-3.606503,"marketCap":407880521},{"date":"2024-12-27","current":-3.256545,"twenty":-15.585849,"median":-12.510288,"eighty":-3.394584,"marketCap":419999921},{"date":"2025-01-03","current":-2.91955,"twenty":-15.427152,"median":-12.339512,"eighty":-3.24488,"marketCap":376537243},{"date":"2025-01-10","current":-3.007039,"twenty":-15.189107,"median":-10.412935,"eighty":-3.188498,"marketCap":387820823},{"date":"2025-01-17","current":-2.520987,"twenty":-15.022781,"median":-6.676265,"eighty":-3.159983,"marketCap":325134267},{"date":"2025-01-24","current":-2.715408,"twenty":-14.870188,"median":-6.06727,"eighty":-3.071846,"marketCap":350208890},{"date":"2025-01-31","current":-2.469142,"twenty":-14.351372,"median":-4.794107,"eighty":-2.968155,"marketCap":318447701},{"date":"2025-02-07","current":-2.54367,"twenty":-14.313224,"median":-3.888412,"eighty":-2.841781,"marketCap":328059640},{"date":"2025-02-14","current":-2.313605,"twenty":-14.275075,"median":-3.716674,"eighty":-2.653842,"marketCap":298388004},{"date":"2025-02-21","current":-2.530708,"twenty":-14.268972,"median":-3.643766,"eighty":-2.622086,"marketCap":326387998},{"date":"2025-02-28","current":-2.141867,"twenty":-14.163683,"median":-3.476889,"eighty":-2.54367,"marketCap":276238754},{"date":"2025-03-07","current":-2.35573,"twenty":-14.007233,"median":-3.332693,"eighty":-2.517747,"marketCap":303820838},{"date":"2025-03-14","current":-2.324434,"twenty":-13.840892,"median":-3.246824,"eighty":-2.465902,"marketCap":364908203},{"date":"2025-03-21","current":-2.26852,"twenty":-13.569102,"median":-3.188498,"eighty":-2.360915,"marketCap":356130342},{"date":"2025-03-28","current":-2.138053,"twenty":-13.499383,"median":-3.165816,"eighty":-2.351842,"marketCap":335648668},{"date":"2025-04-04","current":-2.076814,"twenty":-13.408148,"median":-3.159335,"eighty":-2.284767,"marketCap":326034820},{"date":"2025-04-11","current":-1.80523,"twenty":-13.315978,"median":-3.071846,"eighty":-2.26652,"marketCap":283399498},{"date":"2025-04-17","current":-2.21793,"twenty":-13.154764,"median":-2.997318,"eighty":-2.257224,"marketCap":348188468},{"date":"2025-04-25","current":-2.657256,"twenty":-13.051602,"median":-2.943853,"eighty":-2.261324,"marketCap":417157373},{"date":"2025-05-02","current":-3.077944,"twenty":-13.023813,"median":-2.968155,"eighty":-2.26639,"marketCap":483200324},{"date":"2025-05-09","current":-2.4756,"twenty":-13.008271,"median":-2.943853,"eighty":-2.269325,"marketCap":388639550},{"date":"2025-05-16","current":-2.503456,"twenty":-12.890356,"median":-2.890387,"eighty":-2.270833,"marketCap":407464932},{"date":"2025-05-23","current":-2.942974,"twenty":-12.763909,"median":-2.866084,"eighty":-2.272453,"marketCap":479001383},{"date":"2025-05-30","current":-2.570283,"twenty":-12.665077,"median":-2.835832,"eighty":-2.278934,"marketCap":418341820},{"date":"2025-06-06","current":-2.470042,"twenty":-12.521189,"median":-2.721889,"eighty":-2.297829,"marketCap":402026489},{"date":"2025-06-13","current":-2.90956,"twenty":-12.426717,"median":-2.835832,"eighty":-2.31327,"marketCap":473562940},{"date":"2025-06-20","current":-2.392933,"twenty":-12.365673,"median":-2.76689,"eighty":-2.315238,"marketCap":389476234},{"date":"2025-06-27","current":-2.608837,"twenty":-12.215932,"median":-2.714219,"eighty":-2.322158,"marketCap":424616947},{"date":"2025-07-03","current":-2.577994,"twenty":-11.896022,"median":-2.691086,"eighty":-2.323707,"marketCap":419596845},{"date":"2025-07-11","current":-3.102331,"twenty":-8.929847,"median":-2.679496,"eighty":-2.324434,"marketCap":504938576},{"date":"2025-07-18","current":-3.387633,"twenty":-8.364044,"median":-2.699206,"eighty":-2.336288,"marketCap":551374518},{"date":"2025-07-25","current":-4.194702,"twenty":-6.676265,"median":-2.718649,"eighty":-2.349239,"marketCap":682733850},{"date":"2025-08-01","current":-4.037914,"twenty":-6.187126,"median":-2.829882,"eighty":-2.35573,"marketCap":657214999},{"date":"2025-08-08","current":-3.804019,"twenty":-6.06727,"median":-2.865865,"eighty":-2.35573,"marketCap":619145893},{"date":"2025-08-15","current":-3.987237,"twenty":-5.542498,"median":-2.90956,"eighty":-2.36209,"marketCap":705768845},{"date":"2025-08-22","current":-4.02768,"twenty":-4.889717,"median":-2.928692,"eighty":-2.362211,"marketCap":712927599},{"date":"2025-08-29","current":-3.868286,"twenty":-4.698498,"median":-2.950685,"eighty":-2.372371,"marketCap":684713689},{"date":"2025-09-05","current":-4.039575,"twenty":-4.396216,"median":-2.982091,"eighty":-2.374493,"marketCap":715033114},{"date":"2025-09-12","current":-4.798483,"twenty":-4.881439,"median":-2.99503,"eighty":-2.389351,"marketCap":849365013},{"date":"2025-09-19","current":-4.629572,"twenty":-4.881439,"median":-3.063777,"eighty":-2.399463,"marketCap":819466690},{"date":"2025-09-26","current":-4.429735,"twenty":-4.835595,"median":-3.074895,"eighty":-2.402603,"marketCap":784094028},{"date":"2025-10-03","current":-4.984046,"twenty":-4.911724,"median":-3.083269,"eighty":-2.409912,"marketCap":882211057},{"date":"2025-10-10","current":-6.604159,"twenty":-5.180553,"median":-3.135974,"eighty":-2.413574,"marketCap":1168982288},{"date":"2025-10-17","current":-5.759607,"twenty":-5.320916,"median":-3.162575,"eighty":-2.420654,"marketCap":1019490677},{"date":"2025-10-24","current":-5.949928,"twenty":-5.76722,"median":-3.174048,"eighty":-2.42495,"marketCap":1053178928},{"date":"2025-10-31","current":-9.035303,"twenty":-6.083769,"median":-3.188498,"eighty":-2.432369,"marketCap":1599311910},{"date":"2025-11-07","current":-9.81546,"twenty":-6.198298,"median":-3.245204,"eighty":-2.444339,"marketCap":1737405107},{"date":"2025-11-14","current":-10.08009,"twenty":-6.457611,"median":-3.282468,"eighty":-2.446909,"marketCap":1914199059},{"date":"2025-11-21","current":-9.848299,"twenty":-7.258864,"median":-3.371139,"eighty":-2.451734,"marketCap":1870182143},{"date":"2025-11-28","current":-10.976161,"twenty":-8.972029,"median":-3.394997,"eighty":-2.453948,"marketCap":2084362015},{"date":"2025-12-05","current":-10.772637,"twenty":-9.459248,"median":-3.515773,"eighty":-2.459247,"marketCap":2045713016},{"date":"2025-12-12","current":-11.366249,"twenty":-9.83041,"median":-3.643766,"eighty":-2.466418,"marketCap":2158439264},{"date":"2025-12-19","current":-9.913314,"twenty":-9.980024,"median":-3.678075,"eighty":-2.469682,"marketCap":1882528351},{"date":"2025-12-26","current":-12.202958,"twenty":-10.134363,"median":-3.729636,"eighty":-2.472265,"marketCap":2317329596},{"date":"2026-01-02","current":-10.263827,"twenty":-10.232168,"median":-3.760324,"eighty":-2.476253,"marketCap":1949090517},{"date":"2026-01-09","current":-4.638651,"twenty":-10.207521,"median":-3.79333,"eighty":-2.479511,"marketCap":880875114},{"date":"2026-01-16","current":-5.633657,"twenty":-10.159019,"median":-3.831007,"eighty":-2.483289,"marketCap":1069825778},{"date":"2026-01-23","current":-5.766513,"twenty":-10.142278,"median":-3.88256,"eighty":-2.488034,"marketCap":1095054986},{"date":"2026-01-30","current":-5.902195,"twenty":-10.122491,"median":-3.950232,"eighty":-2.490604,"marketCap":1120820986},{"date":"2026-02-06","current":-5.938943,"twenty":-10.119664,"median":-3.975342,"eighty":-2.498305,"marketCap":1127799277},{"date":"2026-02-13","current":-7.380571,"twenty":-10.08009,"median":-4.008147,"eighty":-2.503456,"marketCap":1401563024},{"date":"2026-02-20","current":-7.637803,"twenty":-9.946669,"median":-4.026371,"eighty":-2.50452,"marketCap":1450411065},{"date":"2026-02-27","current":-7.451239,"twenty":-9.897484,"median":-4.035344,"eighty":-2.514003,"marketCap":1414982815},{"date":"2026-03-06","current":-7.140299,"twenty":-9.857345,"median":-4.041954,"eighty":-2.520051,"marketCap":1355935733},{"date":"2026-03-13","current":-6.925469,"twenty":-9.824447,"median":-4.068124,"eighty":-2.528764,"marketCap":1315139567},{"date":"2026-03-20","current":-3.549457,"twenty":-9.816065,"median":-4.041954,"eighty":-2.535893,"marketCap":1340761298},{"date":"2026-03-27","current":-3.365681,"twenty":-9.764845,"median":-4.035344,"eighty":-2.542374,"marketCap":1271342335},{"date":"2026-04-02","current":-3.206266,"twenty":-9.752191,"median":-4.02768,"eighty":-2.54367,"marketCap":1211125146},{"date":"2026-04-10","current":-3.351146,"twenty":-9.585134,"median":-4.008147,"eighty":-2.555011,"marketCap":1265851823},{"date":"2026-04-17","current":-3.426736,"twenty":-9.459248,"median":-3.975342,"eighty":-2.562572,"marketCap":1294404871},{"date":"2026-04-24","current":-2.91178,"twenty":-9.318941,"median":-3.950232,"eighty":-2.56484,"marketCap":1099887227},{"date":"2026-05-01","current":-3.042488,"twenty":-9.220114,"median":-3.88256,"eighty":-2.568711,"marketCap":1149260207},{"date":"2026-05-08","current":-3.034614,"twenty":-9.118797,"median":-3.818719,"eighty":-2.573367,"marketCap":1146285931},{"date":"2026-05-15","current":-2.806581,"twenty":-9.04377,"median":-3.782641,"eighty":-2.576966,"marketCap":1193220825},{"date":"2026-05-22","current":-2.946168,"twenty":-8.972029,"median":-3.74498,"eighty":-2.576966,"marketCap":1252566199},{"date":"2026-05-29","current":-2.756092,"twenty":-8.703526,"median":-3.716674,"eighty":-2.577994,"marketCap":1171755477},{"date":"2026-06-05","current":-2.729363,"twenty":-8.073548,"median":-3.672934,"eighty":-2.577994,"marketCap":1160391469},{"date":"2026-06-12","current":-2.637295,"twenty":-7.609535,"median":-3.597675,"eighty":-2.580331,"marketCap":1121248775},{"date":"2026-06-18","current":-2.759062,"twenty":-7.566764,"median":-3.544789,"eighty":-2.584211,"marketCap":1173018144},{"date":"2026-06-26","current":-3.663405,"twenty":-7.560564,"median":-3.528998,"eighty":-2.58741,"marketCap":1557500410},{"date":"2026-07-02","current":-4.157898,"twenty":-7.541694,"median":-3.549457,"eighty":-2.594231,"marketCap":1767734556},{"date":"2026-07-10","current":-4.370248,"twenty":-7.462546,"median":-3.643766,"eighty":-2.595516,"marketCap":1858015285},{"date":"2026-07-17","current":-4.193537,"twenty":-7.451239,"median":-3.672934,"eighty":-2.596017,"marketCap":1782886566},{"date":"2026-07-24","current":-4.601902,"twenty":-7.448412,"median":-3.716674,"eighty":-2.598756,"marketCap":1956503353},{"date":"2026-07-31","current":-4.791978,"twenty":-7.400923,"median":-3.74498,"eighty":-2.598756,"marketCap":2037314075},{"date":"2026-08-07","current":-4.777128,"twenty":-7.389051,"median":-3.770746,"eighty":-2.606821,"marketCap":2031000738},{"date":"2026-08-14","current":-3.929032,"twenty":-7.382267,"median":-3.79905,"eighty":-2.610296,"marketCap":1903160311},{"date":"2026-08-21","current":-4.254657,"twenty":-7.371525,"median":-3.831007,"eighty":-2.614149,"marketCap":2060887981}],"updateTime":1787538685881},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ZBIO\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2661227355","title":"China's InnoCare Pharma H1 Revenue Surges, Partly on Orelabrutinib Growth","url":"https://stock-news.laohu8.com/highlight/detail?id=2661227355","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661227355?lang=en_us&edition=fundamental","pubTime":"2026-08-24 17:44","pubTimestamp":1787564642,"startTime":"0","endTime":"0","summary":"China's InnoCare Pharma H1 revenue surges, partly on orelabrutinib growthOverviewChina biopharmaceutical firm's H1 revenue grew 55.5% yr/yr, driven by drug sales and collaborationsAdjusted net income ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260824:nL1N44L0AM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","HK0000320264.USD","ZBIO","BK1191","688428","02696","BK0239","BK4139","HK0000165453.HKD","HK0000306685.HKD","BK1574","HK0000306701.USD","HK0000320223.HKD","09969","BK1230","BK1583","06996","00656"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660724494","title":"Zenas BioPharma Grants 11,000 RSUs to Newly Hired Employees Under 2026 Inducement Plan","url":"https://stock-news.laohu8.com/highlight/detail?id=2660724494","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660724494?lang=en_us&edition=fundamental","pubTime":"2026-08-19 04:15","pubTimestamp":1787084130,"startTime":"0","endTime":"0","summary":"Zenas BioPharma grants 11,000 RSUs to newly hired employees under 2026 inducement planZenas BioPharma granted 11,000 restricted stock units to newly hired employees on Aug. 17, 2026.Awards vest in fou","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260818:nNDL2L1pVb:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014021.USD","SG9999014013.SGD","BCDF","IE00BQXX3D17.EUR","NDAQ","LU0314104364.USD","IE00B64PRP62.GBP","IE00B3QW5Z07.USD","LU2210149790.SGD","IE00BGHQF748.EUR","SG9999014039.USD","IE00BQXX3C00.GBP","IE00BN0W2T93.GBP","LU2095319765.USD","LU2210150020.SGD","ZBIO","IE00BN0W2W23.USD","BK4112","IE00BQXX3F31.USD","IE00BN0W2V16.EUR","SG9999014005.SGD","BK4585","BK4588","BK4139","IE00BKPKM429.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660790494","title":"Zenas Biopharma Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2660790494","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660790494?lang=en_us&edition=fundamental","pubTime":"2026-08-19 04:15","pubTimestamp":1787084100,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260818:nTUA5RFYW4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ZBIO","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660492131","title":"Zenas BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2660492131","media":"GlobeNewswire","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660492131?lang=en_us&edition=fundamental","pubTime":"2026-08-19 04:15","pubTimestamp":1787084100,"startTime":"0","endTime":"0","summary":"WALTHAM, Mass., Aug.  18, 2026 (GLOBE NEWSWIRE) -- Zenas BioPharma, Inc. (“Zenas” or the “Company”) (Nasdaq: ZBIO), a clinical-stage global biopharmaceutical company committed to being a leader in the","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/08/18/3347237/0/en/zenas-biopharma-announces-inducement-grants-under-nasdaq-listing-rule-5635-c-4.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","LCLG","ZBIO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660882574","title":"Zenas BioPharma reports Q2 EPS ($1.77), consensus (75c)","url":"https://stock-news.laohu8.com/highlight/detail?id=2660882574","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660882574?lang=en_us&edition=fundamental","pubTime":"2026-08-17 16:02","pubTimestamp":1786953770,"startTime":"0","endTime":"0","summary":"Reports Q2 revenue $1M, consensus $15M. “2026 continues to be a transformative year for Zenas, highlighted by FDA acceptance of the obexelimab BLA ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/zenas-biopharma-reports-q2-eps-1-77-consensus-75c-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/zenas-biopharma-reports-q2-eps-1-77-consensus-75c-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ZBIO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660488406","title":"Zenas BioPharma CFO Jennifer Fox to transition out of role","url":"https://stock-news.laohu8.com/highlight/detail?id=2660488406","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660488406?lang=en_us&edition=fundamental","pubTime":"2026-08-17 16:01","pubTimestamp":1786953693,"startTime":"0","endTime":"0","summary":"The company announced that Jennifer Fox will transition from her current role as CFO and chief business officer to serve in a new role as strategic...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/zenas-biopharma-cfo-jennifer-fox-to-transition-out-of-role-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/zenas-biopharma-cfo-jennifer-fox-to-transition-out-of-role-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CFO","ZBIO","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659314416","title":"Zenas BioPharma Price Target Maintained with a $45.00/Share by Wedbush","url":"https://stock-news.laohu8.com/highlight/detail?id=2659314416","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659314416?lang=en_us&edition=fundamental","pubTime":"2026-08-14 21:17","pubTimestamp":1786713420,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/ZBIO/analyst-ratings","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ZBIO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659606141","title":"Morgan Stanley Reaffirms Their Hold Rating on Zenas BioPharma, Inc. (ZBIO)","url":"https://stock-news.laohu8.com/highlight/detail?id=2659606141","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659606141?lang=en_us&edition=fundamental","pubTime":"2026-08-14 20:38","pubTimestamp":1786711114,"startTime":"0","endTime":"0","summary":"Morgan Stanley analyst Judah Frommer maintained a Hold rating on Zenas BioPharma, Inc. today and set a price target of $32.00. According to TipRank...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/morgan-stanley-reaffirms-their-hold-rating-on-zenas-biopharma-inc-zbio-blurbs-news-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/morgan-stanley-reaffirms-their-hold-rating-on-zenas-biopharma-inc-zbio-blurbs-news-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ZBIO","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659149496","title":"Zenas BioPharma, Inc. (ZBIO) Receives a Buy from Guggenheim","url":"https://stock-news.laohu8.com/highlight/detail?id=2659149496","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659149496?lang=en_us&edition=fundamental","pubTime":"2026-08-14 20:18","pubTimestamp":1786709896,"startTime":"0","endTime":"0","summary":"Guggenheim analyst Yatin Suneja reiterated a Buy rating on Zenas BioPharma, Inc. yesterday and set a price target of $55.00. The company’s shares c...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/zenas-biopharma-inc-zbio-receives-a-buy-from-guggenheim-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/zenas-biopharma-inc-zbio-receives-a-buy-from-guggenheim-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ZBIO","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659414358","title":"Analysts Offer Insights on Healthcare Companies: MDxHealth (MDXH), Opko Health (OPK) and Zenas BioPharma, Inc. (ZBIO)","url":"https://stock-news.laohu8.com/highlight/detail?id=2659414358","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659414358?lang=en_us&edition=fundamental","pubTime":"2026-08-14 18:40","pubTimestamp":1786704009,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on MDxHealth (MDXH), Opko Health (OPK) and Zenas BioPharma, Inc. (ZB...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-mdxhealth-mdxh-opko-health-opk-and-zenas-biopharma-inc-zbio-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-mdxhealth-mdxh-opko-health-opk-and-zenas-biopharma-inc-zbio-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4196","BK4581","MDXH","LU0029874061.USD","BK4588","XLV","HCSG","XBI","BK4139","BK4137","LU0128526141.USD","OPK","LABU","ZBIO","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659413154","title":"Zenas BioPharma Searches for CFO as Fox Transitions to Advisory Role","url":"https://stock-news.laohu8.com/highlight/detail?id=2659413154","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659413154?lang=en_us&edition=fundamental","pubTime":"2026-08-13 20:20","pubTimestamp":1786623600,"startTime":"0","endTime":"0","summary":"Zenas BioPharma is searching for a new finance chief.The company on Thursday said Jennifer Fox will leave her current role as chief financial and business officer, transitioning to the role of strategic adviser to the board chair, effective Sept. 30.Joe Farmer, who currently serves as president and chief operating officer, will serve as principal financial officer and principal accounting officer until the appointment of a new finance chief, Zenas BioPharma said.The leadership update came as Zenas BioPharma said its second-quarter  loss widened to $111.5 million, or $1.77 a share, from a loss of $52.2 million, or $1.25 a share, in the prior-year period. Total revenue ticked up to $1 million from nil.Chief Executive Lonnie Moulder said the company is actively preparing for the potential commercialization of its first product, continuing to execute across its portfolio and make progress toward its vision of becoming a fully integrated, global development and commercial-stage biopharmaceu","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ZBIO","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659115487","title":"Zenas BioPharma, Inc. Reports Results for the Quarter Ended June 30 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2659115487","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659115487?lang=en_us&edition=fundamental","pubTime":"2026-08-13 20:06","pubTimestamp":1786622806,"startTime":"0","endTime":"0","summary":"Zenas BioPharma, Inc. reports results for the quarter ended June 30 - Earnings SummaryZenas BioPharma, Inc.ZBIO.OQreported a quarterly adjusted loss of $1.29 per share for the quarter ended June 30, l","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260813:nL8N44A158:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ZBIO","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659656159","title":"Zenas BioPharma Q2 EPS $(1.77) Misses $(1.08) Estimate, Sales $1.000M Miss $18.750M Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2659656159","media":"Benzinga Earnings","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659656159?lang=en_us&edition=fundamental","pubTime":"2026-08-13 19:24","pubTimestamp":1786620258,"startTime":"0","endTime":"0","summary":"Zenas BioPharma (NASDAQ:ZBIO) reported quarterly losses of $(1.77) per share which missed the analyst consensus estimate of $(1.08) by 63.89 percent. This is a 41.6 percent decrease over losses of $(1.25) per share from","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/08/61169669/zenas-biopharma-q2-eps-1-77-misses-1-08-estimate-sales-1-000m-miss-18-750m-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ZBIO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659159398","title":"Zenas Biopharma Posts Corporate Presentation on Autoimmune Disease Pipeline, Led by Obexelimab Program","url":"https://stock-news.laohu8.com/highlight/detail?id=2659159398","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659159398?lang=en_us&edition=fundamental","pubTime":"2026-08-13 19:22","pubTimestamp":1786620124,"startTime":"0","endTime":"0","summary":"Zenas Biopharma posts corporate presentation on autoimmune disease pipeline, led by obexelimab programZenas Biopharma outlined a near-term regulatory path for obexelimab in IgG4-RD, with an FDA decisi","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260813:nNDL7gjMxX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ZBIO","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659156407","title":"Earnings Flash (ZBIO) Zenas BioPharma Posts Q2 Loss $1.77 a Share, vs. FactSet Est of $1.12 Loss","url":"https://stock-news.laohu8.com/highlight/detail?id=2659156407","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659156407?lang=en_us&edition=fundamental","pubTime":"2026-08-13 19:12","pubTimestamp":1786619560,"startTime":"0","endTime":"0","summary":"Earnings Flash (ZBIO) Zenas BioPharma Posts Q2 Loss $1.77 a Share, vs. FactSet Est of $1.12 Loss","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["ZBIO","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659156616","title":"Zenas BioPharma Q2 FY26 Net Loss Widens to $111.5 Million; Revenue Rises to $1 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2659156616","media":"Reuters","labels":["executive","dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659156616?lang=en_us&edition=fundamental","pubTime":"2026-08-13 19:04","pubTimestamp":1786619050,"startTime":"0","endTime":"0","summary":"Zenas BioPharma Q2 FY26 net loss widens to $111.5 million; revenue rises to $1 millionZenas posted Q2 2026 net loss of $111.5 million, widening from $52.2 million a year earlier.Revenue was $1 million","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260813:nNDL48cq6n:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive,dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","LU2095319765.USD","LU2210149790.SGD","IE00BKPKM429.USD","SG9999014013.SGD","BCDF","IE00BGHQF748.EUR","IE00BN0W2V16.EUR","LU0314104364.USD","SG9999014039.USD","BK4588","IE00BN0W2T93.GBP","IE00B3QW5Z07.USD","SG9999014005.SGD","NDAQ","IE00BN0W2W23.USD","IE00B64PRP62.GBP","BK4139","SG9999014021.USD","BK4112","LU2210150020.SGD","ZBIO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659415626","title":"Zenas Biopharma, Inc.: Qtrly EPS $-1.77","url":"https://stock-news.laohu8.com/highlight/detail?id=2659415626","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659415626?lang=en_us&edition=fundamental","pubTime":"2026-08-13 19:00","pubTimestamp":1786618803,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260813:nTUA8PJN1G:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ZBIO","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659155751","title":"Press Release: Zenas BioPharma Reports Second Quarter 2026 Financial Results and Provides Corporate Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2659155751","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659155751?lang=en_us&edition=fundamental","pubTime":"2026-08-13 19:00","pubTimestamp":1786618800,"startTime":"0","endTime":"0","summary":"Company's Biologics License Application  for obexelimab for the. treatment of Immunoglobulin G4-Related Disease : The BLA has a. Prescription Drug User Fee Act  target action date of May 27,2027. Zenas expects to submit a Marketing Authorization Application . to the European Medicines Agency  in the second half of 2026.-- Positive results from the Phase 3 INDIGO registrational trial of. obexelimab for the treatment of IgG4-RD presented at EULAR and published. in NEJM in June 2026: Additional data from the INDIGO trial presented at","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SLE","EMA","MAA","BK4215","BK4077","BK4585","SPRE","ZBIO","BK4588","BK4081","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657520170","title":"Biopharma Firm Xencor's Q2 Revenue Beats on Royalty Revenue, Milestone Payments","url":"https://stock-news.laohu8.com/highlight/detail?id=2657520170","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657520170?lang=en_us&edition=fundamental","pubTime":"2026-08-06 04:13","pubTimestamp":1785960830,"startTime":"0","endTime":"0","summary":"Biopharma firm Xencor's Q2 revenue beats on royalty revenue, milestone paymentsOverviewUS biopharma firm's Q2 revenue rose, beating analyst expectationsCompany posted narrower net loss of $21.7 mln, o","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260805:nL1N4421AV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ZBIO","KYMR","BK4139","BK4539","IMRX","BK4563","XNCR","PBE","RPRX","BK4007","IHE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652280744","title":"Zenas BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2652280744","media":"GlobeNewswire","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652280744?lang=en_us&edition=fundamental","pubTime":"2026-07-18 04:15","pubTimestamp":1784319300,"startTime":"0","endTime":"0","summary":"WALTHAM, Mass., July  17, 2026 (GLOBE NEWSWIRE) -- Zenas BioPharma, Inc. (“Zenas” or the “Company”) (Nasdaq: ZBIO), a clinical-stage global biopharmaceutical company committed to being a leader in the","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/07/17/3329284/0/en/Zenas-BioPharma-Announces-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-c-4.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ZBIO","LCLG"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":6,"pageCount":1,"totalSize":109,"code":"91000000","status":"200"}]}}